Fleur van Oosterom

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Risk Assessment

Mesenchymal Stem Cells

Top Venues

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Masmudur M Rahman, Fleur van Oosterom, Junior A Enow, Maksuda Hossain, Ami D Gutierrez-Jensen, Mackenzie Cashen, Anne Everts, Kenneth Lowe, Jacquelyn Kilbourne, Juliane Daggett-Vondras, Timothy L Karr, Grant McFadden
Nuclear Export Inhibitor Selinexor Enhances Oncolytic Myxoma Virus Therapy against Cancer. Cancer research communications 3 (6) (2023)
Masmudur M Rahman, Fleur van Oosterom, Junior A Enow, Maksuda Hossain, Ami D Gutierrez-Jensen, Mackenzie Cashen, Anne Everts, Kenneth Lowe, Jacquelyn Kilbourne, Juliane Daggett-Vondras, Timothy L Karr, Grant McFadden
Nuclear Export Inhibitor Selinexor Enhances Oncolytic Myxoma Virus Therapy against Cancer. Cancer research communications 3 (6) (2023)
Masmudur M Rahman, Fleur van Oosterom, Junior A Enow, Maksuda Hossain, Ami D Gutierrez-Jensen, Mackenzie Cashen, Anne Everts, Kenneth Lowe, Jacquelyn Kilbourne, Juliane Daggett-Vondras, Timothy L Karr, Grant McFadden
Nuclear Export Inhibitor Selinexor Enhances Oncolytic Myxoma Virus Therapy against Cancer. Cancer research communications 3 (6) (2023)
Masmudur M Rahman, Fleur van Oosterom, Junior A Enow, Maksuda Hossain, Ami D Gutierrez-Jensen, Mackenzie Cashen, Anne Everts, Kenneth Lowe, Jacquelyn Kilbourne, Juliane Daggett-Vondras, Timothy L Karr, Grant McFadden
Nuclear Export Inhibitor Selinexor Enhances Oncolytic Myxoma Virus Therapy against Cancer. Cancer research communications 3 (6) (2023)
Masmudur M Rahman, Fleur van Oosterom, Junior A Enow, Maksuda Hossain, Ami D Gutierrez-Jensen, Mackenzie Cashen, Anne Everts, Kenneth Lowe, Jacquelyn Kilbourne, Juliane Daggett-Vondras, Timothy L Karr, Grant McFadden
Nuclear Export Inhibitor Selinexor Enhances Oncolytic Myxoma Virus Therapy against Cancer. Cancer research communications 3 (6) (2023)